DRKS00000117尚未招募不适用

on-Eosinophilic vs. eosinophilic asthma: phenotypical characteristics and gene expression

Koordinierungszentrum für Klinische Studiender Philipps Universität Marburg0 个研究点目标入组 40 人开始时间: 2009年4月17日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Diagnosis of Asthma according to GINA guidelines
•- Reversible airway obstruction (FEV1 > 12 % and 200 ml) post 400 µl Salbutamol

•- COPD or any other disease of the respiratory system (except athma)
•- Respiratory tract infections within 30 days before timepoint -1
•- Systemic or inhaled corticosteroids within 3 months prior before timepoint -1
•- Non-stable phenotype regarding sputum-eosinophilia at timepoint 0
•- Beta-blocker
•- Active smoking or ex-smoking for less than 1 year
•- Smoking > 1 packyear
•- Significant diseases other than asthma. A significant disease is defined as a disease or condition which, in the opinion of the investigator, may put the patient at risk because
•of participation in the study.
•- Planned hospitalization during the course of the study
•- Any clinically relevant abnormal result (lab or clincal) at the timepoints -1 and 0
•- Patients who are currently participating in another study

发起方

Koordinierungszentrum für Klinische Studiender Philipps Universität Marburg